The Life Sciences team
Our Life Sciences team are experts in advising researchers on what steps they should take to protect their intellectual property and create robust innovations to attract industry investment.
Life Sciences Technologies
Method for stable integration of genes that boosts product expression in yeast
Method to increase expression yields
Modulators of Class IIa HDACs
New potent and selective inhibitors of class IIa HDAC enzymes
Clec9a targeted vaccination for virus-mediated autoimmune disease
Novel approach to prevent progression of viral-associated autoimmune diseases
IBD therapeutic derived from gut microbial metabolites
IBD therapeutic with comparable reduction in disease severity to biologic therapies
Peptide activator of ACE-2 for kidney diseases and inflammation
A peptide derived from snake venom that is useful for the treatment of kidney diseases and inflammation.Â
Knock-in genetic barcodes for multiplexed single-cell sequencing
A method for barcoding human cells with proprietary barcodes
Potent and selective inhibitors of human β-factor XIIa
A potential therapeutic strategy for the safe prevention of artificial surface-induced thrombosis.
CAST gene editing platform
Enabling genomic integration of heterologous gene sequences or single base editing
Advanced bioscaffolds for dental applications
Advanced biomaterials for orofacial regeneration and augmentation

Head of Life Sciences
Craig Belcher
Craig is a senior management professional with more than 20 years' experience in commercialising technology within the biotechnology and nanotechnology industries. He leads a team that identifies, patents and commercialises intellectual property from The University of Queensland related to human health, from therapeutics to diagnostics, genomics and the microbiome, to medical devices, as well as biological sciences, food and agriculture.
Innovation Pipelines
We have a suite of available technologies to give your business an innovative edge.